RE:This could be goodIf the secondary recovery pilots prove to have strong results, reaching $8 from here should be peanuts. Even at today's price, the shares are trading at less than 60% of it 2P NAV.
That means lots of run room for the share price if they experience strong secondary results. There is really no good reason why this stock should not be trading at $10 even now.